Want to see GB:SYNT full AI Analyst Report?
Top Page
Synthomer
(LSE:SYNT)
Select Model
Select Model
Rating:46Neutral
Price Target:
76.00 p
â–²(34.99% Upside)
Action:Reiterated
Date:06/27/26
The score is held down primarily by weak financial performance (multi-year losses and inconsistent revenue) and bearish technical momentum (below key short-term averages with negative MACD and low RSI). Debt reduction by 2025 and the rebound in 2025 operating/free cash flow provide partial support, while valuation is difficult to assess positively due to a loss-driven negative P/E and no dividend yield data.
Positive Factors
Balance-sheet improvement
Sharp debt reduction by 2025 materially improves financial flexibility and lowers refinancing and interest-rate vulnerability. Sustained lower leverage gives management scope to fund capex, product investments or restructuring without immediate external financing, supporting durable recovery potential.
Negative Factors
Sustained profitability weakness
Multi-year negative operating profit and net margins erode equity and constrain the company's ability to fund growth internally. Persistent losses weaken pricing power and limit reinvestment in R&D or commercial expansion, making long-term recovery dependent on meaningful margin restoration.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance-sheet improvement
Sharp debt reduction by 2025 materially improves financial flexibility and lowers refinancing and interest-rate vulnerability. Sustained lower leverage gives management scope to fund capex, product investments or restructuring without immediate external financing, supporting durable recovery potential.
Read all positive factors
Synthomer (SYNT) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£130.83M
Dividend YieldN/A
Average Volume (3M)1.10M
Price to Earnings (P/E)―
Beta (1Y)1.39
Revenue Growth-12.46%
EPS Growth-116.21%
CountryUK
Employees4,000
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.92
Shares Outstanding163,997,630
10 Day Avg. Volume933,327
30 Day Avg. Volume1,097,050
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.11
Price to Sales (P/S)0.06
P/FCF Ratio2.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£85.67Price Target Upside52.16% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)£1.90B
Synthomer Business Overview & Revenue Model
Company Description
Synthomer plc functions as a leading producer of specialty chemicals, with its operations organized into four primary divisions: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company develops and...
How the Company Makes Money
Synthomer makes money primarily by manufacturing and selling specialty polymer products (notably emulsions/latices and other performance polymers) to industrial customers, generating revenue from product sales under supply agreements and spot/cont...
Synthomer Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
54
Neutral
Cash Flow
49
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.74B | 1.99B | 1.97B | 2.33B | 2.14B |
| Gross Profit | 167.40M | 337.70M | 307.30M | 281.00M | 569.70M |
| EBITDA | 137.00M | 83.00M | 113.40M | 139.40M | 394.40M |
| Net Income | -157.00M | -72.60M | -67.00M | -32.50M | 208.70M |
Balance Sheet | |||||
| Total Assets | 2.28B | 2.54B | 2.71B | 3.15B | 2.55B |
| Cash, Cash Equivalents and Short-Term Investments | 189.90M | 225.80M | 371.30M | 227.70M | 505.30M |
| Total Debt | 818.50M | 878.70M | 926.30M | 1.30B | 663.00M |
| Total Liabilities | 1.37B | 1.43B | 1.54B | 2.11B | 1.52B |
| Stockholders Equity | 900.80M | 1.09B | 1.15B | 1.02B | 1.02B |
Cash Flow | |||||
| Free Cash Flow | 36.60M | -124.10M | 66.00M | 45.00M | 193.20M |
| Operating Cash Flow | 124.30M | -33.50M | 150.00M | 135.80M | 275.40M |
| Investing Cash Flow | -65.00M | -61.70M | 107.70M | -850.10M | -78.60M |
| Financing Cash Flow | -96.80M | -45.90M | -90.90M | 414.50M | 118.50M |
Synthomer Technical Analysis
Negative
56.30
Price Trends
92.53
Negative
61.63
Positive
60.69
Positive
Market Momentum
-2.50
Positive
36.09
Neutral
4.10
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SYNT, the sentiment is Negative. The current price of 56.3 is below the 20-day moving average (MA) of 99.88, below the 50-day MA of 92.53, and below the 200-day MA of 60.69, indicating a neutral trend. The MACD of -2.50 indicates Positive momentum. The RSI at 36.09 is Neutral, neither overbought nor oversold. The STOCH value of 4.10 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:SYNT.
Synthomer Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £216.40M | 9.57 | 18.25% | 2.00% | 7.24% | ― | |
66 Neutral | £4.22B | 67.86 | 2.82% | 3.45% | 4.38% | -60.87% | |
63 Neutral | £500.69M | -25.00 | -4.95% | 9.48% | -1.24% | -166.15% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | £878.15M | 21.66 | -6.85% | 1.34% | -21.51% | 7.34% | |
46 Neutral | £130.83M | -0.87 | -16.66% | ― | -12.46% | -116.21% | |
46 Neutral | £226.60M | 109.45 | 0.79% | 2.44% | -0.13% | -82.00% |
* Basic Materials Sector Average
GB:SYNT
Synthomer
79.80
-13.20
-14.19%
GB:CRDA
Croda International
3,024.00
171.34
6.01%
GB:ELM
Elementis
153.80
-3.48
-2.22%
GB:ESNT
Essentra
79.90
-24.69
-23.61%
GB:VCT
Victrex
575.00
-140.94
-19.69%
GB:ZTF
Zotefoams
440.00
120.35
37.65%
Synthomer Corporate Events
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Synthomer ties CEO awards to turnaround, share price recovery targets
Positive
Jun 26, 2026
Synthomer has granted new performance share plan awards and a substantial one-off retention package to chief executive Michael Willome, aligning his incentives with financial, strategic and sustainability targets. The PSP awards, covering 2026 to ...
Business Operations and StrategyExecutive/Board ChangesStock BuybackFinancial DisclosuresRegulatory Filings and ComplianceShareholder Meetings
Synthomer AGM backs all resolutions as investors flag concern over CEO retention pay
Neutral
Jun 22, 2026
Synthomer shareholders approved all resolutions at the latest annual general meeting, including the adoption of the 2025 financial statements, renewal of the authority to allot shares, and multiple board elections and re-elections, confirming Pric...
Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Synthomer lifts H1 performance, accelerates transformation amid volatile markets
Positive
Jun 22, 2026
Synthomer reported strong first-half trading in 2026, with volume, revenue, EBITDA and margins up across its continuing operations, driven by improving momentum in Coatings Construction Solutions and stable Adhesive Solutions. The company highlig...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Synthomer exits upstream acrylate monomers in push toward speciality focus
Positive
Jun 19, 2026
Synthomer has agreed to sell Synthomer a.s., its Acrylate Monomers business in the Czech Republic, to German investment group Mutares SE Co. KGaA, removing its last upstream base chemicals asset. The unit, a major European supplier of acrylic aci...
Regulatory Filings and Compliance
Synthomer Sets Updated Total Voting Rights at 163.9 Million Shares
Neutral
May 29, 2026
Synthomer has confirmed that its issued ordinary share capital currently comprises 163,997,629 ordinary shares of £0.01 each, with every share carrying one vote at general meetings. The company also stated that it does not hold any shares in ...
Regulatory Filings and ComplianceShareholder Meetings
Synthomer Publishes 2026 AGM Notice and Governance Documents
Positive
May 22, 2026
Synthomer plc has published the notice of its 2026 annual general meeting on its website and confirmed the meeting will take place on 22 June 2026 in the morning. The company has also made the AGM notice, proxy form and its 2025 annual report and ...
Delistings and Listing ChangesRegulatory Filings and Compliance
Synthomer Adds 430,000 Fully Fungible Shares to LSE Listing
Neutral
May 8, 2026
Synthomer plc has increased its issued share capital through the admission of 430,008 additional ordinary shares to trading on the London Stock Exchange’s Main Market. Following this admission on 8 May 2026, the company’s total number ...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Synthomer Issues New Shares to Lenders as Part of Debt Refinancing
Neutral
May 7, 2026
Synthomer has issued 430,008 new ordinary shares, equivalent to about 0.26% of its enlarged share capital, to certain lenders as payment for fees linked to the recent refinancing of its key debt facilities and following the publication of its 2025...
Financial DisclosuresRegulatory Filings and ComplianceShareholder Meetings
Synthomer files 2025 annual report and sets date for 2026 AGM
Neutral
Apr 30, 2026
Synthomer has published its annual report and accounts for the year ended 31 December 2025 and has submitted the document to the U.K. National Storage Mechanism in line with listing obligations. The report is available on the company’s websi...
Executive/Board Changes
Synthomer CFO Defers Part of 2025 Bonus Into Company Shares
Positive
Apr 30, 2026
Synthomer disclosed that its chief financial officer, Lily Liu, has deferred part of her 2025 annual cash bonus into ordinary shares of the company, aligning a portion of her remuneration more closely with shareholder returns. The transaction, exe...
Business Operations and StrategyExecutive/Board Changes
Synthomer CEO Defers 2025 Bonus Into Company Shares
Positive
Apr 30, 2026
Synthomer has disclosed that Chief Executive Officer Michael Willome has deferred part of his 2025 annual cash bonus into ordinary shares of the company. The transaction, executed on the London Stock Exchange on 30 April 2026, involved the acquisi...
Business Operations and StrategyExecutive/Board Changes
Synthomer appoints interim CFO as Lily Liu departs for Umicore
Neutral
Apr 30, 2026
Synthomer has announced a leadership transition in its finance function, with Chief Financial Officer and Executive Director Lily Liu set to leave at the end of May to become CFO of Belgian materials and recycling group Umicore. Liu, who joined in...
Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Synthomer Lifts Margins and Cash Flow as It Refocuses on Speciality Polymers
Positive
Apr 30, 2026
Synthomer reported 2025 results in line with expectations, with revenue down 10% on weaker end‑market demand but further margin gains from cost savings and portfolio mix, and resilient EBITDA of £136.5m. Strong free cash flow turned pos...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.